ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.

Bo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.